A fourth dose of Omicron RBD vaccine enhances broad neutralization against SARS‐CoV‐2 variants including BA.1 and BA.2 in vaccinated mice

The SARS‐CoV‐2 vaccines have been widely used to build an immunologic barrier in the population against the COVID‐19 pandemic. However, a newly emerging Omicron variant, including BA.1, BA.1.1, BA.2, and BA.3 sublineages, largely escaped the neutralization of existing neutralizing antibodies (nAbs),...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Bing, Song, Shuo, Guo, Huimin, Zhou, Xinrong, Fan, Qing, Liu, Weilong, Cheng, Lin, Ge, Xiangyang, Ju, Bin, Zhang, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088529/
https://www.ncbi.nlm.nih.gov/pubmed/35474319
http://dx.doi.org/10.1002/jmv.27811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088529/
https://www.ncbi.nlm.nih.gov/pubmed/35474319
http://dx.doi.org/10.1002/jmv.27811

Ejemplares similares